相关实验视频

Updated: Jun 15, 2025

Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease

Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease

Published on: December 26, 2016

助长阿尔茨海默病:免疫代谢在哪里?

Sónia C Correia^1,2,3, George Perry⁴, Paula I Moreira^1,2,5

¹Center for Neuroscience and Cell Biology (CNC), University of Coimbra, Coimbra, Portugal.

Journal of Alzheimer's disease : JAD

|August 23, 2024

概括

阿尔茨海默氏病 (AD) 研究现在突出显示大脑免疫细胞,如微质细胞和星球细胞,以及它们的新陈代谢. 了解免疫代谢是开发神经炎症和AD认知衰退的新疗法的关键.

科学领域:

神经科学是一个神经科学.
免疫学免疫学免疫学
代谢过程中的代谢.

背景情况:

阿尔茨海默病 (AD) 病理学是复杂的,从以神经元为中心的观点向包括大脑居民免疫细胞的转变.
全基因组关联研究表明微质细胞和星球细胞与阿尔茨海默病的进展有关.
神经元 - 星细胞 - 微细胞三元体的破坏有助于AD的神经炎症和神经退行.

研究的目的:

对阿尔茨海默病中脑内免疫细胞代谢模式的当前知识进行审查.
专注于葡萄糖,氨基酸和脂质代谢在AD病理中的作用.
强调免疫代谢在阿尔茨海默氏症研究中的重要性.

主要方法:

对阿尔茨海默病和免疫代谢研究的文献综述.
在AD连续期内分析微质和星体中的代谢重编程.
综合有关AD相关的免疫细胞中葡萄糖,氨基酸和脂质代谢的当前发现.

主要成果:

大脑中的免疫细胞,特别是小质细胞和星球细胞,在阿尔茨海默病中经历了显著的代谢重编程.
葡萄糖,氨基酸和脂质代谢的变化在AD病变发生过程中至关重要.
免疫代谢提供了对驱动AD的炎症过程的关键见解.

结论:

将免疫代谢纳入AD研究提供了新的治疗途径.
针对大脑免疫细胞中的代谢途径可能会抑制神经炎症和神经退行.
了解免疫细胞代谢对于未来的AD治疗策略至关重要.

关键词:

阿尔茨海默氏症是阿尔茨海默氏症的一种疾病.氨基酸是氨基酸中的一种.星球细胞是星球细胞.葡萄糖葡萄糖葡萄糖葡萄糖脂质脂质脂质是一种代谢代谢代谢代谢微质细胞中的微质细胞

更多相关视频

Detecting Amyloid-β Accumulation via Immunofluorescent Staining in a Mouse Model of Alzheimer's Disease

Detecting Amyloid-β Accumulation via Immunofluorescent Staining in a Mouse Model of Alzheimer's Disease

Published on: April 19, 2021

Cell-based Assay to Study Antibody-mediated Tau Clearance by Microglia

Cell-based Assay to Study Antibody-mediated Tau Clearance by Microglia

Published on: November 9, 2018

相关概念视频

Alzheimer's Disease: Overview

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...

Alzheimer's Disease: Treatment

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...